FR2374036A1 - Compositions pharmaceutiques contenant de la 3-phenoxypyridine - Google Patents

Compositions pharmaceutiques contenant de la 3-phenoxypyridine

Info

Publication number
FR2374036A1
FR2374036A1 FR7737158A FR7737158A FR2374036A1 FR 2374036 A1 FR2374036 A1 FR 2374036A1 FR 7737158 A FR7737158 A FR 7737158A FR 7737158 A FR7737158 A FR 7737158A FR 2374036 A1 FR2374036 A1 FR 2374036A1
Authority
FR
France
Prior art keywords
phenoxypyridine
pharmaceutical compositions
compositions containing
unit dose
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7737158A
Other languages
English (en)
Other versions
FR2374036B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of FR2374036A1 publication Critical patent/FR2374036A1/fr
Application granted granted Critical
Publication of FR2374036B1 publication Critical patent/FR2374036B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques. Il s'agit d'une composition pharmaceutique orale sous forme de doses unitaires capable d'induire une psychostimulation, comprenant de 1 à 500 mg par unité de dose de 3-phénoxypyridine ou de sels d'addition d'acides de ce corps utilisables en pharmacie et un support pharmaceutique. Ces compositions permettent notamment d'améliorer les capacités d'apprentissage des sujets traités.
FR7737158A 1976-12-17 1977-12-09 Compositions pharmaceutiques contenant de la 3-phenoxypyridine Granted FR2374036A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/751,830 US4067983A (en) 1976-12-17 1976-12-17 Pharmaceutical compositions and methods

Publications (2)

Publication Number Publication Date
FR2374036A1 true FR2374036A1 (fr) 1978-07-13
FR2374036B1 FR2374036B1 (fr) 1980-03-14

Family

ID=25023676

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7737158A Granted FR2374036A1 (fr) 1976-12-17 1977-12-09 Compositions pharmaceutiques contenant de la 3-phenoxypyridine

Country Status (13)

Country Link
US (1) US4067983A (fr)
JP (1) JPS5953884B2 (fr)
AU (1) AU514828B2 (fr)
BE (1) BE861648A (fr)
CA (1) CA1087987A (fr)
DE (1) DE2755017A1 (fr)
FR (1) FR2374036A1 (fr)
GB (1) GB1560247A (fr)
HK (1) HK3984A (fr)
IL (1) IL53578A (fr)
NZ (1) NZ185928A (fr)
PH (1) PH13130A (fr)
ZA (1) ZA777358B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
US4434169A (en) 1983-01-03 1984-02-28 Warner-Lambert Company Pharmaceutical compositions and methods
US4666926A (en) * 1986-02-27 1987-05-19 Warner-Lambert Company Transdermal formulations
US5232934A (en) * 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH434868A (de) * 1964-02-10 1967-04-30 Ciba Geigy Schädlingsbekämpfungsmittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1971 *

Also Published As

Publication number Publication date
DE2755017A1 (de) 1978-06-29
NZ185928A (en) 1984-05-31
BE861648A (fr) 1978-03-31
US4067983A (en) 1978-01-10
AU3141577A (en) 1979-06-14
IL53578A (en) 1980-11-30
DE2755017C2 (fr) 1988-02-04
JPS5379038A (en) 1978-07-13
GB1560247A (en) 1980-01-30
ZA777358B (en) 1979-07-25
IL53578A0 (en) 1978-03-10
PH13130A (en) 1979-12-12
FR2374036B1 (fr) 1980-03-14
HK3984A (en) 1984-01-20
AU514828B2 (en) 1981-02-26
CA1087987A (fr) 1980-10-21
JPS5953884B2 (ja) 1984-12-27

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
BE900660A (fr) Composition therapeutique pour le traitement des sequelles d'intoxication.
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
FR2378523A1 (fr) Medicament pour le traitement de l'acne
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
DE68902301D1 (de) Diarylverbindungen als antiatherosklerotische mittel.
TNSN98113A1 (fr) Procede de preparation de composes utiles pour le traitement de la resistance a l'insuline.
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
FR2375867A1 (fr) Medicament a base de dehydro-oligopeptides destine a la resolution d'une tumeur ou d'un tissu
DZ1324A1 (fr) Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine
SE8600658D0 (sv) Novel composition of matter
KR890004705A (ko) 항바이러스성 제제
FR2427097A1 (fr) Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine
ZA828639B (en) Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
FR2358893A1 (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
FR2374044A1 (fr) Agent anti-diabetique oral contenant une sulfonyluree et une kinine
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet

Legal Events

Date Code Title Description
ST Notification of lapse